← FDA Drug Approvals (Drugs@FDA)

METHYLERGONOVINE MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2018-05-15

Drug application

FDA Application #

ANDA210424

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLERGONOVINE MALEATE

Generic name

METHYLERGONOVINE MALEATE

Active ingredients

METHYLERGONOVINE MALEATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GRANULES

Manufacturer

Granules Pharmaceuticals Inc.

First approval

2018-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown